NMDA Receptor
NMDA (N-methyl-D-aspartate) receptor is a glutamate-gated cation channels that plays a vital role in regulating synaptic transmission, neuroplasticity and central nervous system development. It is involved in a range of physiological processes such as learning, memory and pain etc.
Products Related to NMDA Receptor(77)
- GC11585TCN 237 dihydrochlorideCAS: 700878-19-9Purity: >98.00%
TCN 237 dihydrochloride is a potent and NR2B-selective NMDA antagonist with Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM; no activities on NR2A, NR2C, NR2D, hERG-channel and α1-adrenergic receptor.
- GC11715Ibotenic acidCAS: 2552-55-8Purity: >98.00%
Ibotenic acid is a neurotoxin that has agonist activity at both N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolite quisqualate (Qm) receptor sites.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11064 | Spermine tetrahydrochloride | 306-67-2 | >99.00% | |
NMDA receptor modulator | ||||
| GC11124 | Lanicemine | 153322-05-5 | >95.00% | |
voltage-dependent NMDA channel blocker | ||||
| GC11281 | N20C hydrochloride | 1177583-87-7 | >98% | |
NMDA receptor antagonist | ||||
| GC11286 | ACBC | 22264-50-2 | >98.00% | |
ACBC is a NMDA receptor partial agonist acting at the glycine site, NR1. | ||||
| GC11335 | DL-AP7 | 78966-69-5 | >98% | |
first generation phosphono NMDA antagonist | ||||
| GC11585 | TCN 237 dihydrochloride | 700878-19-9 | >98.00% | |
TCN 237 dihydrochloride is a potent and NR2B-selective NMDA antagonist with Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM; no activities on NR2A, NR2C, NR2D, hERG-channel and α1-adrenergic receptor. | ||||
| GC11706 | L-701,252 | 151057-13-5 | >98% | |
glycine-NMDA site antagonist | ||||
| GC11715 | Ibotenic acid | 2552-55-8 | >98.00% | |
Ibotenic acid is a neurotoxin that has agonist activity at both N-methyl-D-aspartate (NMDA) and trans-ACPD or metabolite quisqualate (Qm) receptor sites. | ||||
| GC11862 | LY 233053 | 125546-04-5 | >98% | |
Competitive NMDA receptor antagonist | ||||
| GC11879 | PPPA | 113190-92-4 | >98% | |
NMDA receptor antagonist | ||||
| GC11942 | cis-ACPD | 477331-06-9 | >98% | |
NMDA receptor agonist and group II mGluR agonist | ||||
| GC12137 | CCMQ | 132623-44-0 | >98% | |
inhibits [3H]-homoquinolinic acid binding to non-NMDA sensitive sites | ||||
| GC12154 | L-AP5 | 79055-67-7 | >98% | |
NMDA antagonist | ||||
| GC12488 | (RS)-(Tetrazol-5-yl)glycine | 138199-51-6 | >98% | |
NMDA receptor agonist | ||||
| GC12785 | ZD 9379 | 170142-20-8 | >98% | |
NMDA receptor antagonist | ||||
| GC12816 | SDZ 220-040 | 174575-40-7 | >98% | |
NMDA receptor antagonist | ||||
| GC12873 | LY 235959 | 137433-06-8 | >98% | |
NMDA receptor antagonist | ||||
| GC12944 | Conantokin-R | 202925-60-8 | >98% | |
non-competitive NMDA receptor antagonist | ||||
| GC13074 | HU 211 | 112924-45-5 | >98% | |
NMDA antagonist, novel and non-competitive | ||||
| GC13714 | Conantokin G | 93438-65-4 | >98% | |
NR2B-selective NMDA receptor antagonist | ||||
| GC14085 | (R)-(+)-HA-966 | 123931-04-4 | >98% | |
NMDA receptor antagonist/partial agonist | ||||
| GC14121 | GLYX 13 | 117928-94-6 | >98% | |
GLYX 13 (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist. | ||||
| GC14236 | (R)-CPP | 126453-07-4 | >95.00% | |
NMDA antagonist | ||||
| GC14357 | PMPA (NMDA antagonist) | 113919-36-1 | >98% | |
Competitive NMDA receptor antagonist | ||||
